229 related articles for article (PubMed ID: 24621445)
1. New age of biological therapies in paediatric rheumatology.
Sen ES; Ramanan AV
Arch Dis Child; 2014 Jul; 99(7):679-85. PubMed ID: 24621445
[TBL] [Abstract][Full Text] [Related]
2. Republished: new age of biological therapies in paediatric rheumatology.
Sen ES; Ramanan AV
Postgrad Med J; 2014 Oct; 90(1068):590-6. PubMed ID: 25230947
[TBL] [Abstract][Full Text] [Related]
3. Network in pediatric rheumatology: the example of pediatric rheumatology international trials organisation.
Ruperto N; Martini A
Georgian Med News; 2008 Mar; (156):68-74. PubMed ID: 18403813
[TBL] [Abstract][Full Text] [Related]
4. New advances in the management of juvenile idiopathic arthritis--2: the era of biologicals.
Beresford MW; Baildam EM
Arch Dis Child Educ Pract Ed; 2009 Oct; 94(5):151-6. PubMed ID: 19770495
[TBL] [Abstract][Full Text] [Related]
5. Impact of the European paediatric legislation in paediatric rheumatology: past, present and future.
Ruperto N; Vesely R; Saint-Raymond A; Martini A;
Ann Rheum Dis; 2013 Dec; 72(12):1893-6. PubMed ID: 23962457
[TBL] [Abstract][Full Text] [Related]
6. New advances in the management of juvenile idiopathic arthritis--1: non-biological therapy.
Beresford MW; Baildam EM
Arch Dis Child Educ Pract Ed; 2009 Oct; 94(5):144-50. PubMed ID: 19770494
[TBL] [Abstract][Full Text] [Related]
7. Networking in paediatrics: the example of the Paediatric Rheumatology International Trials Organisation (PRINTO).
Ruperto N; Martini A
Arch Dis Child; 2011 Jun; 96(6):596-601. PubMed ID: 21317432
[TBL] [Abstract][Full Text] [Related]
8. International research networks in pediatric rheumatology: the PRINTO perspective.
Ruperto N; Martini A
Curr Opin Rheumatol; 2004 Sep; 16(5):566-70. PubMed ID: 15314496
[TBL] [Abstract][Full Text] [Related]
9. Juvenile idiopathic arthritis - an update on pharmacotherapy.
Kahn P
Bull NYU Hosp Jt Dis; 2011; 69(3):264-76. PubMed ID: 22035441
[TBL] [Abstract][Full Text] [Related]
10. Remittive agents in pediatric rheumatology.
Singer NG; Scalzi LV
Curr Opin Rheumatol; 2004 Sep; 16(5):571-6. PubMed ID: 15314497
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of biologics in polyarticular-course juvenile idiopathic arthritis patients unresponsive to disease-modifying antirheumatic drugs.
Ungar WJ; Costa V; Hancock-Howard R; Feldman BM; Laxer RM
Arthritis Care Res (Hoboken); 2011 Jan; 63(1):111-9. PubMed ID: 20740607
[TBL] [Abstract][Full Text] [Related]
12. Juvenile idiopathic arthritis--current and future therapies.
Kahn P
Bull NYU Hosp Jt Dis; 2009; 67(3):291-302. PubMed ID: 19852753
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary complications of biological therapies in children and adults with rheumatic diseases.
Nisar MK; Ostör AJ
Paediatr Respir Rev; 2013 Dec; 14(4):236-41. PubMed ID: 23462434
[TBL] [Abstract][Full Text] [Related]
14. Disease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapies.
Vidqvist KL; Malin M; Varjolahti-Lehtinen T; Korpela MM
Rheumatology (Oxford); 2013 Nov; 52(11):1999-2003. PubMed ID: 23893666
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids in paediatric rheumatology.
Ravelli A; Lattanzi B; Consolaro A; Martini A
Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S148-52. PubMed ID: 22018202
[TBL] [Abstract][Full Text] [Related]
16. Introducing new tools for assessment of parent- and child-reported outcomes in paediatric rheumatology practice: a work in progress.
Filocamo G; Consolaro A; Ferrari C; Ravelli A
Clin Exp Rheumatol; 2013; 31(6):964-8. PubMed ID: 23981398
[TBL] [Abstract][Full Text] [Related]
17. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.
Tynjälä P; Vähäsalo P; Tarkiainen M; Kröger L; Aalto K; Malin M; Putto-Laurila A; Honkanen V; Lahdenne P
Ann Rheum Dis; 2011 Sep; 70(9):1605-12. PubMed ID: 21623000
[TBL] [Abstract][Full Text] [Related]
18. Economic issues with new rheumatologic therapeutics.
Kavanaugh A
Curr Opin Rheumatol; 2007 May; 19(3):272-6. PubMed ID: 17414954
[TBL] [Abstract][Full Text] [Related]
19. Paediatric rheumatology--a global perspective.
Sawhney S; Magalhães CS
Best Pract Res Clin Rheumatol; 2006 Apr; 20(2):201-21. PubMed ID: 16546053
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register.
Prince FH; Twilt M; ten Cate R; van Rossum MA; Armbrust W; Hoppenreijs EP; van Santen-Hoeufft M; Koopman-Keemink Y; Wulffraat NM; van Suijlekom-Smit LW
Ann Rheum Dis; 2009 May; 68(5):635-41. PubMed ID: 18413443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
